Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“Seoul in a week. Nine trials in two Presidential Symposia will answer questions we have been arguing about for a decade:
whether PCI survives the MRI era in SCLC, whether topotecan is finished as a comparator once two B7-H3 ADCs report side by side, and whether exon 20 gets one standard or two. Bring your skepticism.”
